Accelrys Announces Release Of Discovery Studio 2.0 - Quick Facts

Accelrys Inc. (ACCL) announced the release of Discovery Studio 2.0, the most advanced modeling and simulation software environment for drug discovery available today.

Because it is built upon SciTegic Pipeline Pilot, Accelrys' scientific operating platform, Discovery Studio 2.0 is an extensible virtual discovery environment that lets researchers integrate any tool they need to create solutions that are uniquely tailored to fit their research process.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com